Milestone Pharmaceuticals Stock Today
| MIST Stock | USD 1.63 0.01 0.61% |
Performance3 of 100
| Odds Of DistressOver 82
|
Milestone Pharmaceuticals is selling for under 1.63 as of the 23rd of April 2024; that is -0.61 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 1.6. Milestone Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Milestone Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 9th of May 2019 | Category Healthcare | Classification Health Care |
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company was incorporated in 2003 and is headquartered in Montral, Canada. Milestone Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 53.15 M outstanding shares of which 559.53 K shares are now shorted by private and institutional investors with about 1.11 trading days to cover. More on Milestone Pharmaceuticals
Follow Valuation Options Odds of Bankruptcy
Financial Report 9th of May 2024
Milestone Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Milestone Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Milestone Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO | Joseph MBA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Milestone Pharmaceuticals report their recommendations after researching Milestone Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Milestone Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Milestone Pharmaceuticals. The Milestone consensus assessment is calculated by taking the average forecast from all of the analysts covering Milestone Pharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Milestone Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Milestone Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Milestone Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Milestone Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Milestone Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Milestone Pharmaceuticals' financial leverage. It provides some insight into what part of Milestone Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Milestone Pharmaceuticals (MIST) is traded on NASDAQ Exchange in USA. It is located in 1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6 and employs 47 people. Milestone Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 87.17 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Milestone Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Milestone Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Milestone Pharmaceuticals conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 53.15 M outstanding shares of which 559.53 K shares are now shorted by private and institutional investors with about 1.11 trading days to cover.
Milestone Pharmaceuticals currently holds about 86.24 M in cash with (46.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Milestone Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationMilestone Pharmaceuticals holds a total of 53.15 Million outstanding shares. 30% of Milestone Pharmaceuticals outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Milestone Ownership Details
Milestone Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Milestone Pharmaceuticals jumping above the current price in 90 days from now is about 52.49%. The Milestone Pharmaceuticals probability density function shows the probability of Milestone Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Milestone Pharmaceuticals has a beta of 0.2356. This indicates as returns on the market go up, Milestone Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Milestone Pharmaceuticals will be expected to be much smaller as well. Additionally, milestone Pharmaceuticals has an alpha of 0.2644, implying that it can generate a 0.26 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Milestone Pharmaceuticals to move above the current price in 90 days from now is about 52.49 (This Milestone Pharmaceuticals probability density function shows the probability of Milestone Stock to fall within a particular range of prices over 90 days) .
Milestone Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Milestone Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Milestone Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Milestone Pharmaceuticals' value.| Instituion | Recorded On | Shares | |
| Boxer Capital Llc | 2023-12-31 | 309 K | |
| Citadel Advisors Llc | 2023-09-30 | 296.3 K | |
| Barclays Plc | 2023-12-31 | 255.2 K | |
| Dimensional Fund Advisors, Inc. | 2023-12-31 | 73.7 K | |
| Ancora Advisors Llc | 2023-12-31 | 50 K | |
| Northern Trust Corp | 2023-12-31 | 32 K | |
| Clear Creek Investment Mgmt Llc | 2023-12-31 | 31.8 K | |
| Boothbay Fund Management, Llc | 2023-12-31 | 27.6 K | |
| State Street Corporation | 2023-12-31 | 21.6 K | |
| Blackrock Inc | 2023-12-31 | 3.3 M | |
| Rtw Investments, Llc | 2023-12-31 | 3.3 M |
Milestone Pharmaceuticals Historical Income Statement
Milestone Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Milestone's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Milestone Pharmaceuticals revenue and expense. Milestone Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Milestone Pharmaceuticals' Interest Income is comparatively stable compared to the past year. Depreciation And Amortization is likely to gain to about 627.9 K in 2024, whereas Selling And Marketing Expenses is likely to drop slightly above 8 M in 2024. View More FundamentalsMilestone Stock Against Markets
Picking the right benchmark for Milestone Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Milestone Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Milestone Pharmaceuticals is critical whether you are bullish or bearish towards Milestone Pharmaceuticals at a given time. Please also check how Milestone Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Milestone Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Milestone Pharmaceuticals Corporate Management
Elected by the shareholders, the Milestone Pharmaceuticals' board of directors comprises two types of representatives: Milestone Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Milestone. The board's role is to monitor Milestone Pharmaceuticals' management team and ensure that shareholders' interests are well served. Milestone Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Milestone Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kim Fox | Vice Communications | Profile | |
| Guy Rousseau | SVP Management | Profile | |
| FACC MD | Chief Officer | Profile | |
| FACC FAHA | Chief Board | Profile | |
| Jeff Nelson | Chief Officer | Profile | |
| Lorenz Muller | Chief Officer | Profile |
How to buy Milestone Stock?
Before investing in Milestone Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Milestone Pharmaceuticals. To buy Milestone Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Milestone Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Milestone Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Milestone Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Milestone Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Milestone Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.
Already Invested in Milestone Pharmaceuticals?
The danger of trading Milestone Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Milestone Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Milestone Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Milestone Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Milestone Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Milestone Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Milestone Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Milestone Pharmaceuticals Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Milestone Stock analysis
When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Milestone Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Milestone Pharmaceuticals. If investors know Milestone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Milestone Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share 0.023 | Quarterly Revenue Growth (1.00) | Return On Assets (0.51) | Return On Equity (1.44) |
The market value of Milestone Pharmaceuticals is measured differently than its book value, which is the value of Milestone that is recorded on the company's balance sheet. Investors also form their own opinion of Milestone Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Milestone Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Milestone Pharmaceuticals' market value can be influenced by many factors that don't directly affect Milestone Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Milestone Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Milestone Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Milestone Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.